FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.9  |  FHIR Version n/a  User: [n/a]

562411000001105: Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1737961000001110 Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1737971000001117 Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
16742301000001113 Sinemet 275 tablets (Bristol-Myers Squibb Pharmaceuticals Limited) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16742401000001117 Sinemet 275 tablets (Bristol-Myers Squibb Pharmaceuticals Limited) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37794301000001110 Sinemet 275 tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
55810001000001113 Sinemet 275 tablets (Merck Sharp & Dohme Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
57755801000001115 Sinemet 25mg/250mg tablets (Merck Sharp & Dohme Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Is a Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Is a Co-careldopa 25mg/250mg tablets false Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Is a Co-careldopa 25mg/250mg tablets true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Is a Sinemet 275 false Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Is a Sinemet true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) 90 tablet 9 x 10 tablets Is pack of False Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) 90 tablet 9 x 10 tablets Has AMP True Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) 100 tablet 10 x 10 tablets Has AMP True Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start